Akebia Therapeutics dba Keryx Biopharmaceutials recalls
FDA enforcement reports naming Akebia Therapeutics dba Keryx Biopharmaceutials, Inc as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Feb 24, 2021
- Feb 24, 2021Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured fo…Drug · Akebia Therapeutics dba Keryx Biopharmaceutials, IncFailed Dissolution SpecificationsClass III
- Dec 30, 2020Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for…Drug · Akebia Therapeutics dba Keryx Biopharmaceutials, IncCGMP DeviationsClass II